RxDoctor Payments Data

Kami Bell

Family · Gulfport, MSNPI 1417355694

Payments from drug & device makers

$7,345in general payments, 2019–2025

Across 381 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$2K
  • Gilead$1K
  • Astellas Pharma US Inc$827
  • Merck$739
  • Melinta Therapeutics, LLC$725
  • Paratek Pharmaceuticals, Inc.$528
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$7,11197%
  • Education$2343%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,345 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$53,102
Medicare patients
295
Services billed
911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala100$390,636
CabenuvaCabotegravir/Rilpivirine12$64,740
DovatoDolutegravir Sodium/Lamivudine17$59,264
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf12$53,207
ErtapenemErtapenem Sodium13$9,684
Methenamine Hippurate181$9,097
Atovaquone12$6,175
Meropenem12$4,645
Fosfomycin Tromethamine11$2,182
Rifampin28$1,774
Azithromycin51$1,624
Ethambutol Hcl24$1,408
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$762
Doxycycline Hyclate61$757
Fluconazole39$662

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$1,362$390,636100 claims
Viiv Healthcare CompanyCabenuva, Dovato$1,803$124,00429 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,007 family providers in Mississippi.

Other family in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →